MedPath

Risk Evaluation of Acute Exacerbation After pulmonary resection in Lung Cancer Patients with Interstitial Pneumonia (REVEAL-IP)

Not Applicable
Recruiting
Conditions
ung cancer Interstitial pneumonia
Registration Number
JPRN-UMIN000022626
Lead Sponsor
Japanese Association for Chest Surgery
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
1250
Inclusion Criteria

Not provided

Exclusion Criteria

This is a prospective observational, non-invasive study. Exclusion criteria is not defined in order to guarantee the external validity of the findings, and to be a comprehensive registration and informations gathering.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incident of acute-exacerbation during 30 days after pulmonary resection of lung cancer
Secondary Outcome Measures
NameTimeMethod
Prognosis Cause of death
© Copyright 2025. All Rights Reserved by MedPath